Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients—A Retrospective Single-Center Analysis

Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients—A Retrospective Single-Center Analysis

(1) Background: mRNA COVID-19 vaccines are effective but show varied efficacy in immunocompromised patients, including allogeneic hematopoietic stem cell transplant (HSCT) recipients. (2) Methods: A retrospective study on 167 HSCT recipients assessed humoral response to two mRNA vaccine doses, using...

Full description

Bibliographic Details
Main Authors: Alexander Nikoloudis, Ines Julia Neumann, Veronika Buxhofer-Ausch, Sigrid Machherndl-Spandl, Michaela Binder, Emine Kaynak, Robert Milanov, Stefanie Nocker, Olga Stiefel, Irene Strassl, Dagmar Wipplinger, Margarete Moyses, Heidrun Kerschner, Petra Apfalter, Michael Girschikofsky, Andreas Petzer, Ansgar Weltermann, Johannes Clausen
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Vaccines
Subjects:
COVID-19
HSCT
vaccination
transplantation
Online Access:https://www.mdpi.com/2076-393X/11/10/1534

Internet

https://www.mdpi.com/2076-393X/11/10/1534

Similar Items